{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AURX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AURX\",,,,,undefined,":{"symbol":"AURX","market":"US","secType":"STK","nameCN":"Nuo Therapeutics, Inc.","latestPrice":2.38,"timestamp":1762203600000,"preClose":2,"halted":0,"volume":2992,"delay":15,"floatShares":22864200,"shares":48077700,"eps":-0.063845,"marketStatus":"Not Yet Opened","change":0.38,"latestTime":"11-03 16:00:00 EST Delay","open":2,"high":2.38,"low":2,"amount":6078.37,"amplitude":0.19,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.063845,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1762246800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":2,"volumeRatio":0.678735},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AURX\",,,,,undefined,":{"symbol":"AURX","floatShares":22864200,"roa":"-87.97%","roe":"-1032.50%","lyrEps":-0.029253,"volumeRatio":0.678735,"shares":48077700,"dividePrice":0,"high":2.38,"amplitude":0.19,"preClose":2,"low":2,"week52Low":0.7,"pbRate":"-272.70","psRate":"43.81","week52High":3.23,"institutionHeld":0,"latestPrice":2.38,"eps":-0.063845,"divideRate":0,"volume":2992,"delay":15,"ttmEps":-0.063845,"open":2,"prevYearClose":1.4,"prevWeekClose":2,"prevMonthClose":2,"prevQuarterClose":2.04,"fiveDayClose":2.33,"twentyDayClose":3.23,"sixtyDayClose":1.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AURX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-12","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-19","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713499200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-20","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1700456400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AURX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AURX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579120356","title":"Nuo Therapeutics Inc. Announces Date for Upcoming Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2579120356","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579120356?lang=en_us&edition=fundamental","pubTime":"2025-10-31 01:12","pubTimestamp":1761844323,"startTime":"0","endTime":"0","summary":"Nuo Therapeutics Inc. will hold its Annual Meeting of Stockholders on December 16, 2025, at its principal executive office in Houston, Texas. During the meeting, stockholders will vote on the election of directors, the ratification of the appointment of the independent registered public accounting firm, and an advisory vote on named executive officer compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL8VD1bs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURX"],"gpt_icon":0},{"id":"2574766551","title":"Nuo Therapeutics boosts executive salaries for CEO and COO in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2574766551","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574766551?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:30","pubTimestamp":1760099451,"startTime":"0","endTime":"0","summary":"Nuo Therapeutics Inc. has approved salary increases for its top executives, effective October 1, 2025. David E. Jorden, Chief Executive and Financial Officer, will receive an annual salary of $325,000. Peter A. Clausen, Chief Scientific and Operating Officer, will have his salary set at $290,000. The changes were approved by the company's Board of Directors and Compensation, Nominating and Governance Committee, reflecting improved business and financial performance in 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDLkRqKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURX"],"gpt_icon":0},{"id":"2556849568","title":"Charles E. Sheedy, 10% Owner, Reports Acquisition of Common Shares in Nuo Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2556849568","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556849568?lang=en_us&edition=fundamental","pubTime":"2025-08-02 06:04","pubTimestamp":1754085847,"startTime":"0","endTime":"0","summary":"Charles E. Sheedy, a 10% Owner, reported an acquisition of common shares of Nuo Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL8CR6CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURX"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AURX\",params:#limit:6,delay:false,,,undefined,":[]}}